MAPT and Alzheimer disease: Animal studies and some human studies are beginning to examine whether decreasing the rate of synthesis of tau in the neuron or enhancing its clearance from the neuron (Bennett et al., 2019; Hoskin et al., 2019; Ossenkoppele et al., 2022) can improve the clinical course of Alzheimer's disease.